Table 1.
Study | Number of patients | NYHA class | LVEF (%) | QRS duration (ms) | Primary end point | Effect on primary end point |
---|---|---|---|---|---|---|
REVERSE45 | 610 | I–II | ≤40% | ≥120 | HF clinical composite score | Not significant |
MADIT-CRT46 | 1,820 | I–II | ≤30% | ≥130 | Death from any cause or a nonfatal HF event | Significant |
RAFT50 | 1,798 | II–III | ≤30% | ≥130 | Death from any cause or hospitalization for HF | Significant |
Abbreviations: HF, heart failure; LVEF, left ventricular ejection fraction.